Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
References to these marks are made for descriptive purposes only under principles of nominative fair use and do not imply endorsement, affiliation, or sponsorship unless explicitly stated
Alteration of several metabolic enzymes and pathways that affect KG abundance and KGDD activity have been reported in cancer, such as mutations of the genes encoding isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2), changes in glutaminolysis that deplete KG, and alterations in fumarate hydratase and succinate dehydrogenase that inhibit KGDD activity 11
BPC 157 and TB 500 Blend 10MG is supplied by NuRev Peptides strictly for laboratory research and testing purposes
185 In EGFR-mutant lung cancer, resistance to osimertinib is tightly linked to epigenetic regulation by the ATPase subunit SMARCA4 of the mSWI/SNF complex
